IN2014CH01872A - - Google Patents
Info
- Publication number
- IN2014CH01872A IN2014CH01872A IN1872CH2014A IN2014CH01872A IN 2014CH01872 A IN2014CH01872 A IN 2014CH01872A IN 1872CH2014 A IN1872CH2014 A IN 1872CH2014A IN 2014CH01872 A IN2014CH01872 A IN 2014CH01872A
- Authority
- IN
- India
- Prior art keywords
- nanodispersion
- present disclosure
- exemplary embodiment
- aqueous dispersion
- dispersion medium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Colloid Chemistry (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/302,495 US11458096B2 (en) | 2014-04-09 | 2015-04-08 | Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base |
IN1872CH2014 IN2014CH01872A (es) | 2014-04-09 | 2015-04-08 | |
PCT/IB2015/052541 WO2015155703A2 (en) | 2014-04-09 | 2015-04-08 | Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base |
AU2015246030A AU2015246030B2 (en) | 2014-04-09 | 2015-04-08 | Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base |
MX2016013201A MX2016013201A (es) | 2014-04-09 | 2015-04-08 | Composicion y metodo para producir una nanoformulacion de bioactivos insolubles en agua en una base acuosa. |
EA201692044A EA038458B1 (ru) | 2014-04-09 | 2015-04-08 | Стабильная водная нанодисперсия водонерастворимых биоактивных соединений и способ ее получения |
EP15777362.3A EP3129002A4 (en) | 2014-04-09 | 2015-04-08 | Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1872CH2014 IN2014CH01872A (es) | 2014-04-09 | 2015-04-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014CH01872A true IN2014CH01872A (es) | 2015-05-08 |
Family
ID=54288490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1872CH2014 IN2014CH01872A (es) | 2014-04-09 | 2015-04-08 |
Country Status (7)
Country | Link |
---|---|
US (1) | US11458096B2 (es) |
EP (1) | EP3129002A4 (es) |
AU (1) | AU2015246030B2 (es) |
EA (1) | EA038458B1 (es) |
IN (1) | IN2014CH01872A (es) |
MX (1) | MX2016013201A (es) |
WO (1) | WO2015155703A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11311017B2 (en) | 2014-04-30 | 2022-04-26 | Matoke Holdings Limited | Antimicrobial compositions |
GB201716986D0 (en) | 2017-10-16 | 2017-11-29 | Matoke Holdings Ltd | Antimicrobial compositions |
FR3075661A1 (fr) * | 2017-12-21 | 2019-06-28 | Coatex | Emulsion submicronique |
CN111526862A (zh) * | 2017-12-29 | 2020-08-11 | 欧莱雅 | 用于改变毛发颜色的组合物 |
WO2019175830A1 (en) * | 2018-03-14 | 2019-09-19 | Azista Industries Pvt Ltd | Cholecalciferol nanoemulsion formulations and methods for producing same |
WO2023118928A1 (en) | 2021-12-21 | 2023-06-29 | Opella Healthcare Group Sas | Stable nanoformulation for lipophilic actives, oral dosage form and process for its preparation |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69229779T2 (de) * | 1991-04-19 | 1999-12-23 | Lds Technologies, Inc. | Konvertierbare mikroemulsionsverbindungen |
CA2091152C (en) | 1993-03-05 | 2005-05-03 | Kirsten Westesen | Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof |
US5518738A (en) | 1995-02-09 | 1996-05-21 | Nanosystem L.L.C. | Nanoparticulate nsaid compositions |
AU6708096A (en) | 1995-09-18 | 1997-04-09 | Vesifact Ag | Propofol nanodispersions |
DE19642359A1 (de) | 1996-10-14 | 1998-04-16 | Basf Ag | Stabile Emulsionen und Trockenpulver von Mischungen fettlöslicher Vitamine, deren Herstellung und Verwendung |
US5994414A (en) | 1997-04-28 | 1999-11-30 | Avon Products, Inc. | Water-thin emulsion formed by high pressure homogenization process |
EP1249230B1 (de) * | 2001-04-12 | 2003-11-05 | Vesifact Ag | Coenzym Q10 enthaltende Mikroemulsion-Prekonzentrate und Mikroemulsionen |
US20030228395A1 (en) * | 2002-01-31 | 2003-12-11 | Archer-Daniels Midland Company | Isotropic transparent structured fluids |
US6780324B2 (en) * | 2002-03-18 | 2004-08-24 | Labopharm, Inc. | Preparation of sterile stabilized nanodispersions |
JP2005530822A (ja) | 2002-06-17 | 2005-10-13 | ターロ ファーマシューティカルズ ユーエスエイ インコーポレイテッド | イブプロフェン懸濁液 |
US8628690B2 (en) | 2004-02-23 | 2014-01-14 | The Texas A&M University System | Nanoemulsion compositions and methods of use thereof |
EP1597973A1 (en) | 2004-05-18 | 2005-11-23 | Nestec S.A. | Oil-in-water emulsion for delivery |
US20060051462A1 (en) * | 2004-09-03 | 2006-03-09 | Wang Jimmy X | Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients |
HUE034677T2 (hu) | 2005-12-01 | 2018-02-28 | Univ Massachusetts Lowell | Botulinum nanoemulziók |
CN101011355B (zh) * | 2006-02-01 | 2013-01-02 | 陈献 | 经维生素e琥珀酸酯稳定的医药组合物、其制备及用途 |
WO2007103294A2 (en) | 2006-03-07 | 2007-09-13 | Novavax, Inc. | Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same |
EP1938801A1 (en) | 2006-12-22 | 2008-07-02 | Biofrontera Bioscience GmbH | Nanoemulsion |
JP2011505235A (ja) * | 2007-11-28 | 2011-02-24 | コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション | ナノエマルション |
US9308257B2 (en) * | 2007-11-28 | 2016-04-12 | Medimmune, Llc | Protein formulation |
EP2201937A1 (en) | 2008-12-23 | 2010-06-30 | Teva Pharmaceutical Industries Ltd. | Formulations comprising vitamin D or derivatives thereof |
AU2010222648B2 (en) | 2009-03-09 | 2016-07-07 | Pronova Biopharma Norge As | Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof |
EP2432455B1 (en) * | 2009-05-18 | 2014-11-12 | Sigmoid Pharma Limited | Composition comprising oil drops |
EA201270050A1 (ru) * | 2009-06-19 | 2012-05-30 | Сан Фарма Адвансед Ресёрч Компани Лтд. | Нанодисперсия лекарственного средства и способ ее получения |
CN102933200B (zh) * | 2009-12-18 | 2015-11-25 | 莱迪杜德制药公司 | 包含磷脂的单相凝胶组合物 |
CA3022054A1 (en) * | 2010-03-12 | 2011-09-15 | Berg Llc | Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
US20110229516A1 (en) * | 2010-03-18 | 2011-09-22 | The Clorox Company | Adjuvant phase inversion concentrated nanoemulsion compositions |
SE536746C2 (sv) | 2010-05-12 | 2014-07-08 | Stora Enso Oyj | En komposition innehållande mikrofibrillerad cellulosa och en process för tillverkning av en komposition |
US8835509B2 (en) | 2010-05-31 | 2014-09-16 | Arbro Pharmaceuticals Ltd. | Self emulsifying drug delivery system for a curcuminoid based composition |
US20140004186A1 (en) | 2010-09-08 | 2014-01-02 | Pronova Biopharma Norge As | Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin |
WO2013008083A1 (en) | 2011-07-13 | 2013-01-17 | National Institute Of Pharmaceutical Education And Research (Niper) | Pharmaceutical composition for enhancing anticancer efficacy of tamoxifen |
NZ596015A (en) | 2011-10-26 | 2014-04-30 | Anzamed Internat Ltd | Method and composition for the treatment of pain and/or inflammation |
GB201204377D0 (en) | 2012-03-13 | 2012-04-25 | Givaudan Sa | Composition |
-
2015
- 2015-04-08 WO PCT/IB2015/052541 patent/WO2015155703A2/en active Application Filing
- 2015-04-08 EP EP15777362.3A patent/EP3129002A4/en active Pending
- 2015-04-08 IN IN1872CH2014 patent/IN2014CH01872A/en unknown
- 2015-04-08 AU AU2015246030A patent/AU2015246030B2/en active Active
- 2015-04-08 US US15/302,495 patent/US11458096B2/en active Active
- 2015-04-08 MX MX2016013201A patent/MX2016013201A/es active IP Right Grant
- 2015-04-08 EA EA201692044A patent/EA038458B1/ru unknown
Also Published As
Publication number | Publication date |
---|---|
US11458096B2 (en) | 2022-10-04 |
EP3129002A2 (en) | 2017-02-15 |
EA038458B1 (ru) | 2021-08-31 |
WO2015155703A3 (en) | 2015-12-30 |
US20180177723A1 (en) | 2018-06-28 |
AU2015246030B2 (en) | 2020-03-12 |
MX2016013201A (es) | 2017-04-25 |
EA201692044A1 (ru) | 2017-04-28 |
WO2015155703A2 (en) | 2015-10-15 |
AU2015246030A1 (en) | 2016-11-24 |
EP3129002A4 (en) | 2017-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014CH01872A (es) | ||
EP3548450A4 (en) | FORMULATIONS WITH ACTIVE FUNCTIONAL ADDITIVES FOR 3D PRINTING PRECERAMIC POLYMERS AND METHODS FOR 3D PRINTING FORMULATIONS | |
IL266018A (en) | Methods and systems for improving the stability of the pre-vapor composition of an electronic inhalation device | |
EP3566523A4 (en) | TECHNIQUES FOR AGGREGATION OF DOWNLINK CONTROL INFORMATION MESSAGES | |
EP3215806A4 (en) | 3d imaging, ranging, and/or tracking using active illumination and point spread function engineering | |
MX2021010105A (es) | Particulas de nanoalumbre que contienen un agente de dimensionamiento. | |
MX2019006158A (es) | Sistemas polimerícos para dispersión de partículas. | |
EP3039049A4 (en) | Self-crosslinkable polymer and aqueous dispersion comprising particles of the same | |
PL3229976T3 (pl) | Wodna dyspersja poliuretanopolimocznikowa i wodny lakier bazowy zawierający tę dyspersję | |
JP2015110565A5 (es) | ||
EP3608415A4 (en) | POLYHYDROXY ALKANOATE PARTICLES AND AQUATIC DISPERSION OF THE SAME | |
PL3230336T3 (pl) | Wodna dyspersja poliuretanopolimocznikowa i wodny lakier bazowy zawierający dyspersję | |
EP3295943A4 (en) | Aqueous suspension agent comprising glucocorticosteroid nanoparticles | |
EP3108869A4 (en) | Aqueous dispersion of inorganic powder particles subjected to hydrophobic organic surface treatment, and cosmetic including same | |
HK1225613A1 (zh) | 赖谷胰岛素的稳定制剂 | |
WO2014160185A3 (en) | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof | |
PL3448902T3 (pl) | Wodna dyspersja i jej zastosowania | |
EP2987405A4 (en) | AGROCHEMICAL OIL DISPERSION FORMULATION, USE OF AGROCHEMICAL OIL DISPERSION FORMULATIONS AND METHOD FOR PRODUCING AN AGROCHEMICAL OIL DISPERSION FORMULATION | |
EP3083282A4 (en) | Tires and other objects having an aerodynamic/hydrodynamic surface treatment | |
WO2014172608A3 (en) | Parthenolide derivatives and their modulation of processes controlled by regulated translation | |
EP3287786A3 (en) | Compositions and methods for active surveillance of prostate cancer | |
PH12016500855A1 (en) | Pharmaceutical preparation and method of its production and use | |
EP3546517A4 (en) | AQUEOUS POLYTETRAFLUOROETHYLENE DISPERSION | |
PH12017500700A1 (en) | Stable aqueous dispersions of zinc phosphates | |
EP3104843A4 (en) | Stabilized, sprayable emulsion containing active agent particles |